title: The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
abstract: Glioma is the most common type of human intracranial cancers and has poor prognosis. Bone morphogenetic protein 2 (BMP2) plays important roles in cancer cell signalings (Vecht et al. Oncologist 19:751-9, 2014). Here, we aimed to investigate the correlation of BMP2 with patient prognosis as well as pathological indicators. Immunohistochemistry was used to test BMP2 proteins in 45 gliomas of distinct malignancy grade, and Kaplan-Meier survival analysis was performed to assess prognostic significance. BMP2 protein was also detected in cell lines by Western blot. We observed that BMP2 protein was stained in 44.4% (20 out of 45) of all glioma tissues, including 32.1% of low-grade (I + II) gliomas and 52.9% of high-grade (III + IV) gliomas. Grade IV gliomas potently expressed BMP2 proteins. Western blot showed BMP2 protein expressed in cell lines NHA, A172, T98G, U87, and U251. In addition, BMP2 expression was significantly associated with WHO grade (p = 0.024). According to log-rank test and Cox regression model, BMP2 can be suggested as an independent prognostic factor, apart from WHO grade. Taken together, BMP2 is differently highly expressed in different grades of gliomas and correlated to WHO grade. BMP2 also independently indicates poor prognosis in old glioma patients, which is indicative of an effectively therapeutic target.
authors.affiliation: Department of Pathology, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan, Shandong, China.
authors.forename: Xiangshan
authors.initials: X
authors.lastname: Yang
authors.forename: Daotang
authors.initials: D
authors.lastname: Li
authors.forename: Shaomei
authors.initials: S
authors.lastname: Cheng
authors.forename: Kaixi
authors.initials: K
authors.lastname: Fan
authors.forename: Lijun
authors.initials: L
authors.lastname: Sheng
authors.forename: Jing
authors.initials: J
authors.lastname: Zhang
authors.forename: Bin
authors.initials: B
authors.lastname: Feng
authors.forename: Zhongfa
authors.initials: Z
authors.lastname: Xu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism*; D015153:Blotting, Western; D055396:Bone Morphogenetic Protein 2 / Q000378:metabolism*; D001932:Brain Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D005910:Glioma / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D011379:Prognosis; D015996:Survival Rate; D055815:Young Adult
chemical_list: C525718:BMP2 protein, human; D014408:Biomarkers, Tumor; D055396:Bone Morphogenetic Protein 2
references.citation: Oncologist. 2014 Jul;19(7):751-9
references.pmid: 24899645
references.citation: Carcinogenesis. 2003 Sep;24(9):1445-54
references.pmid: 12819188
references.citation: J Exp Ther Oncol. 2008;7(4):327-38
references.pmid: 19227012
references.citation: Mol Cancer Res. 2004 Mar;2(3):141-9
references.pmid: 15037653
references.citation: Ann Thorac Surg. 2005 Sep;80(3):1028-32
references.pmid: 16122479
references.citation: JAMA. 2013 Nov 6;310(17):1842-50
references.pmid: 24193082
references.citation: Oncol Rep. 2014 Sep;32(3):1013-20
references.pmid: 24993644
references.citation: Ann Diagn Pathol. 2013 Feb;17(1):51-3
references.pmid: 22748688
references.citation: Oncogene. 2006 Feb 2;25(5):685-92
references.pmid: 16247476
references.citation: Bone. 2009 Feb;44(2):233-42
references.pmid: 19038372
references.citation: Mol Cell Endocrinol. 2003 Dec 15;211(1-2):105-13
references.pmid: 14656483
references.citation: Cell Death Dis. 2012 Oct 18;3:e412
references.pmid: 23076220
references.citation: Exp Cell Res. 2011 Jul 15;317(12):1746-62
references.pmid: 21570392
references.citation: Int J Oncol. 2005 Aug;27(2):401-7
references.pmid: 16010421
references.citation: Cancer. 2000 Jun 15;88(12):2887
references.pmid: 10870076
references.citation: Asian Pac J Cancer Prev. 2013;14(9):5293-9
references.pmid: 24175816
references.citation: Bone. 2006 Feb;38(2):154-66
references.pmid: 16126463
references.citation: Exp Cell Res. 2010 Jan 1;316(1):24-37
references.pmid: 19835871
references.citation: J Exp Clin Cancer Res. 2010 Jun 30;29:85
references.pmid: 20587070
references.citation: Cytokine. 1999 Dec;11(12):1031-7
references.pmid: 10623428
references.citation: Int J Dev Biol. 2000 Apr;44(3):253-65
references.pmid: 10853822
references.citation: Acta Neuropathol. 2005 Jan;109(1):93-108
references.pmid: 15685439